Zhuan-You Zhao Selected Research

Zhuan-You Zhao Research Topics

5	Thrombosis (Thrombus) 01/2022 - 11/2006
4	Hemorrhage 01/2022 - 03/2004
3	Cerebral Hemorrhage 01/2022 - 01/2018
2	Alcoholic Fatty Liver 04/2021 - 01/2020
2	Infarction (Infarctions) 11/2019 - 01/2018
1	Unstable Angina 01/2022
1	Cerebral Infarction 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Myocardial Infarction 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Stroke (Strokes) 04/2021
1	Fatty Liver 01/2020
1	Ischemic Stroke 11/2019
1	Thromboembolism 11/2019
1	Embolism (Embolus) 01/2018
1	Retinal Vein Occlusion 06/2014
1	Inflammation (Inflammations) 06/2014

3	Therapeutic UsesIBA 01/2022 - 11/2019
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 03/2004
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 01/2022
2	AnticoagulantsIBA 01/2022 - 11/2006
2	HirudinsIBA 01/2022 - 01/2022
2	Iridoid GlycosidesIBA 04/2021 - 01/2020
2	SugarsIBA 04/2021 - 01/2020
1	sanqiIBA 04/2021
1	Plant ExtractsIBA 04/2021
1	TabletsIBA 04/2021
1	Neuroprotective AgentsIBA 04/2021
1	oxidized low density lipoproteinIBA 01/2020
1	Coloring Agents (Dyes)IBA 11/2019
1	diazonaphthalenedisulfonic acid (NDS)IBA 11/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	triphenyltetrazoliumIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	xuesetongIBA 06/2014
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2006
1	AnnexinsIBA 11/2006
1	FibrinIBA 11/2006
1	Peptides (Polypeptides)IBA 11/2006

1	Intravenous Administration 01/2022
1	Intravenous Infusions 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Thrombolytic Therapy 11/2006